India to United Kingdom: Allopurinol Export Trade Route
India has recorded 337 verified shipments of Allopurinol exported to United Kingdom, representing a combined trade value of $8.5M USD. This corridor is served by 12 active Indian exporters, with an average shipment value of $25.2K USD. The leading Indian exporter is IPCA LABORATORIES LIMITED, which accounts for 72% of total export value with 152 shipments worth $6.2M USD. On the buying side, IPCA LABORATORIES UK LIMITED is the largest importer in United Kingdom with $6.2M USD in purchases. The top 3 suppliers — IPCA LABORATORIES LIMITED, INDOCO REMEDIES LIMITED, HARMAN FINOCHEM LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United Kingdom Allopurinol corridor is one of India's established pharmaceutical export routes, with 337 shipments documented worth a combined $8.5M USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 72% of all export value, reflecting the consolidated nature of India's allopurinol manufacturing sector.
Across 12 active suppliers, the average shipment value stands at $25.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 30.4%, placing it at rank #5 among India's top allopurinol export destinations globally.
On the import side, key buyers of Indian allopurinol in United Kingdom include IPCA LABORATORIES UK LIMITED, NA, ACCORD HEALTHCARE LTD and 11 others. IPCA LABORATORIES UK LIMITED is the single largest importer with 152 shipments valued at $6.2M USD.
